Antares Pharma Inc. clinical trials
Acquired by Halozyme Therapeutics, May 24, 2022 · source ↗
The registry lists 9 studies whose lead sponsor is Antares Pharma Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Apr 19, 2019.
Before and after it joined Halozyme Therapeutics
- First submitted before Antares Pharma Inc. became part of Halozyme Therapeutics
- 9
- First submitted after Antares Pharma Inc. became part of Halozyme Therapeutics
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Antares Pharma Inc.9 studies
Something wrong with this grouping? Tell us on the Halozyme Therapeutics page.
Studies
Recruiting first, then most recently updated. Showing 9 of 9. All Halozyme Therapeutics studies →
- Pharmacokinetic Study of Subcutaneous Testosterone EnanthateCompletedNCT02233751Phase 1
Sponsor listed in the registry: Antares Pharma Inc. · First submitted before Antares Pharma Inc. became part of Halozyme Therapeutics
- Subcutaneous Testosterone Enanthate Safety in Adult Men Diagnosed With HypogonadismCompletedNCT02504541Phase 3
Sponsor listed in the registry: Antares Pharma Inc. · First submitted before Antares Pharma Inc. became part of Halozyme Therapeutics
- Safety of Subcutaneous Testosterone Enanthate in Adult Male HypogonadismCompletedNCT02777242Phase 2
Sponsor listed in the registry: Antares Pharma Inc. · First submitted before Antares Pharma Inc. became part of Halozyme Therapeutics
- Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With HypogonadismCompletedNCT02159469Phase 3
Sponsor listed in the registry: Antares Pharma Inc. · First submitted before Antares Pharma Inc. became part of Halozyme Therapeutics
- Pharmacokinetic Study of Testosterone EnanthateCompletedNCT01887418Phase 1/2
Sponsor listed in the registry: Antares Pharma Inc. · First submitted before Antares Pharma Inc. became part of Halozyme Therapeutics
- Study of Topically Administered Oxybutynin Gel in Patients With Urge IncontinenceCompletedNCT00909181Phase 3
Sponsor listed in the registry: Antares Pharma Inc. · First submitted before Antares Pharma Inc. became part of Halozyme Therapeutics
- Comparison of Methotrexate (MTX) and the VIBEX™ MTX DeviceCompletedNCT01618968Phase 2
Sponsor listed in the registry: Antares Pharma Inc. · First submitted before Antares Pharma Inc. became part of Halozyme Therapeutics
- Actual Human Use of Methotrexate (MTX) Subcutaneously Administered Via the VIBEX™ MTX Auto-Injector DeviceCompletedNCT01618955Phase 2
Sponsor listed in the registry: Antares Pharma Inc. · First submitted before Antares Pharma Inc. became part of Halozyme Therapeutics
- Exposure Study Comparing 3 Routes of Methotrexate (MTX) AdministrationCompletedNCT01737944Phase 1/2
Sponsor listed in the registry: Antares Pharma Inc. · First submitted before Antares Pharma Inc. became part of Halozyme Therapeutics